Hemorrhagic Microangiopathy clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Biomarkers of CASH
open to eligible people ages 18 years and up
The project aims to develop prognostic and diagnostic blood tests for symptomatic brain hemorrhage in patients diagnosed with cavernous angiomas, a critical clinical challenge in a disease affecting more than a million Americans. We further examine whether blood biomarkers can replace or enhance the accuracy of advanced imaging in association with lesional bleeding. The project tests a novel integrational approach of biomarker development in a mechanistically defined cerebrovascular disease, with a clinically relevant context of use.
at UCSF
Last updated: